HBV/HCV infection, alcohol, tobacco and genetic polymorphisms for hepatocellular carcinoma in Nagoya, Japan

Asian Pacific Journal of Cancer Prevention

Volumn 1, Issue 3, 2000, Pages 239-245

  Koide, Tsuneo ^a   Ohno, Tomoyoshi ^a   Huang, Xin En ^a   Iijima, Yoshiko ^a   Sugihara, Kanji ^a   Mizokami, Masashi ^a   Xiang, Jin ^a   Tokudome, Shinkan ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Gene polymorphisms; HCC; Lifestyle

Indexed keywords

EID: 33644535318     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bartsh H, Montesano R (1984). Relevance of nitrosamines to human cancer. Carcinogenesis, 5,1381-93.
2. Borsron WF, Li TK (1986). Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases and their relationship to alcohol metabolism and alcoholism. Hepatology, 6,502-10.
3. Chen CJ, Liang KY, Chang AS, et al. (1991). Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology, 13, 398-406.
4. Donato F, Tagger A, Chiesa R, et al. (1997). Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Hepatology, 26,579-84.
5. Goedde HW, Agarwal DP, Fritze G, et al. (1992).Distribution of ADH2 and ALDH2 genotypes in different populations. Hum Genet, 88, 344-6.
6. Guengerich FP, Shimada T (1991). Oxidation of toxic and carcinogenic chemicals by human cytochrome p-450 enzymes. Chem Res Toxicol, 4,391-407.
7. Hayashi S, Watanabe J, Kawajiri K (1991). Genetic polymorphisms in the 5'-flanking region change transcriptional Regulation of the human cytochrome P4502E1 gene. J Biochem, 110, 559-65.
8. Health and Welfare Statistics Association (1997). Trend in National Public Health. Kosei-no-Shihyo, 44,433-4 (in Japanese).
9. Higuchi S, Matsushita S, Murayama M, et al. (1995). Alcohol and aldehyde dehydrogenase polymorphisms and the risk for alcoholism. Am J Psychiat, 152, 1219-21.
10. Hirayama T (1989). A large-scale cohort study on risk factors for promary liver cancer, with special reference to the role of cigarette smoking. Cancer Chemother Pharmacol, 23 (suppl), s114-17.
11. Hong J, Yang CS (1985). The nature of microsmal Nnitrosodimethylamine demethylase and its role in carcinogen activation. Carcinogenesis, 6,1805-9.
12. Hoofnagle JH, Gerety RJ, Ni LY, Barker LF (1974). Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis virus replicaition. N Engl J Med, 290, 1336-40.
13. Hoofnagle JH, Seefe LB, Bales ZB, Zimmerman HJ. (1978). Type B hepatitis after transfusion with blood containing antibody t hepatitis B core antigen. N Engl J Med, 298, 1379-83.
14. Hoofnagle JH, di Bisceglie AM (1997). The treatment of chronic viral hepatitis. N Engl J Med, 336, 347-56.
15. Kato Y, Nakata K, Omagari K, et al. (1994). Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Cancer, 74, 2234-8.
16. Koop DR (1992). Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J, 6, 724-30.
17. Lee H-S, Yoon J-H, Kamimura S, et al. (1997). Lack of association of cytochrome P4502E1 genetic polymorphisms with the risk of human hepatocellular carcinoma. Int J Cancer, 71, 737-40.
18. Lieber CS (1994). Alcohol and the liver: 1994 update. Gastroenterology, 106, 1085-105.
19. Maezawa Y, Yamauchi M, Toda G (1994). Association between restriction fragment length polymorphism of the human cytochrome p4502E1 gene and susceptibility to alcoholic liver cirrhosis. Amer J Gastroenterol, 89, 561-5.
20. Mohamed AE, Kew MC, Groeneveld HT(1992). Alcohol consumption as a risk factor for hepatocellular carcinoma in urban southern African blacks. Int J Cancer, 51, 537-41.
21. Mori M, Hara M, Wada I, et al. (2000). Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol, 151, 131-9.
22. Parkin, DM, Pisani P, and Ferlay J. (1999). Estimates of the world incidence of 25 major cancers in 1990. Int J Cancer, 80,827-41.
23. Research Group for Population-based Cancer Registration in Japan (1998). Cancer incidence in Japan, 1992-1993. Jpn J Clin Oncol, 28, 641-7.
24. SAS Institute Inc (1990). SAS/STAT users guide, version 5, volume 2, Cary, NC: SAS Institute Inc, 1071-126.
25. Takeshita T, Morimoto K, Mao X, et al. (1994), Characterization of the three genotypes of low Km aldehyde dehydrogenase in a Japanese population. Hum Genet, 94, 217-23.
26. Takeshita T, Yang X, Inoue Y, et al. (2000). Relationship between alcohol drinking, ADH2 and ALDH2 genotypes, and risk for hepatocellular carcinoma in Japanese. Cancer Letters, 149, 69-76.
27. Tanaka K, Hirohata T, Koga S, et al. (1991). Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res, 51, 2842-7.
28. Tsutsumi M, Takada A, Wang J-S (1994). Genetic polymorphisms of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology, 107,1430-5.
29. Tzonou A, Trichopoulos D, Kaklamani E, et al. (1991). Epidemiologic assessment of interactions of hepatitis-C virus with seromarkers of hepatitis-B and -D viruses, cirrhosis and tobacco smoking in hepatocellular carcinoma. Int J Cancer, 49, 377-80.
30. Wolf C, Smith C, Forman D (1994). Metabolic polymorphisms in carcinogen metabolizing enzymes and cancer susceptibility. Br Med Bull, 50, 718-31.
31. Wrighton SA, Thomas PE, Molowa DT, et al. (1986). Characterization of ethanol-inducible human liver N-nitrosodimethylamine demethylase. Biochemistry, 25, 6731-5.
32. Wrighton SA, Thomas PE, Willis P, et al. (1987). Purification of a human liver cytochrome p-450 immunochemically related to several cytochromes p-450 purified from untreated rats. J Clin Invest, 80, 1017-22.
33. Yokoyama A, Muramatsu T, Ohmori T, et al. (1998). Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis, 19, 1383-7.
34. Yoo JS, Guengerich FP, Yang CS (1988). Metabolism of Nnitrosodialkylamines by human liver microsomes. Cancer Res, 48, 1499-504.
35. Yu MW, Gladek-Yarborough A, Chiamprasert S, et al. (1995). Cytochrome P4502E1 and glutathione s-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology, 109, 1266-73.
36. Yu MW, You SL, Chang AS, et al. (1991). Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res, 51, 5621-5.
37. Yuki N, Hayashi N, Kasahara A, et al. (1992). Hepatitis B virus marks and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma. Dig Dis Sci, 37, 65-72.